284 related articles for article (PubMed ID: 29499348)
1. Continuous manufacturing and analytical characterization of fixed-dose, multilayer orodispersible films.
Thabet Y; Lunter D; Breitkreutz J
Eur J Pharm Sci; 2018 May; 117():236-244. PubMed ID: 29499348
[TBL] [Abstract][Full Text] [Related]
2. Continuous inkjet printing of enalapril maleate onto orodispersible film formulations.
Thabet Y; Lunter D; Breitkreutz J
Int J Pharm; 2018 Jul; 546(1-2):180-187. PubMed ID: 29753906
[TBL] [Abstract][Full Text] [Related]
3. From 'fixed dose combinations' to 'a dynamic dose combiner': 3D printed bi-layer antihypertensive tablets.
Sadia M; Isreb A; Abbadi I; Isreb M; Aziz D; Selo A; Timmins P; Alhnan MA
Eur J Pharm Sci; 2018 Oct; 123():484-494. PubMed ID: 30041029
[TBL] [Abstract][Full Text] [Related]
4. Increased drug load and polymer compatibility of bilayered orodispersible films.
Carolina Visser J; Weggemans OAF; Boosman RJ; Loos KU; Frijlink HW; Woerdenbag HJ
Eur J Pharm Sci; 2017 Sep; 107():183-190. PubMed ID: 28709911
[TBL] [Abstract][Full Text] [Related]
5. Orodispersible films: Product transfer from lab-scale to continuous manufacturing.
Thabet Y; Breitkreutz J
Int J Pharm; 2018 Jan; 535(1-2):285-292. PubMed ID: 29146537
[TBL] [Abstract][Full Text] [Related]
6. Orodispersible films in individualized pharmacotherapy: The development of a formulation for pharmacy preparations.
Visser JC; Woerdenbag HJ; Crediet S; Gerrits E; Lesschen MA; Hinrichs WLJ; Breitkreutz J; Frijlink HW
Int J Pharm; 2015 Jan; 478(1):155-163. PubMed ID: 25448577
[TBL] [Abstract][Full Text] [Related]
7. Study of the effect of formulation variables on the characteristics of combination tablets containing enalapril maleate and indapamide as active substances using experimental design.
Szabó ZI; Székely-Szentmiklósi B; Deák B; Székely-Szentmiklósi I; Kovács B; Zöldi K; Sipos E
Acta Pharm; 2016 Jun; 66(2):191-206. PubMed ID: 27279063
[TBL] [Abstract][Full Text] [Related]
8. Development, In Vitro and In Vivo Evaluation of Racecadotril Orodispersible Films for Pediatric Use.
Wang B; Yang L; Wang B; Luo C; Wang Y; Wang H; Chen F; Xiang X
AAPS PharmSciTech; 2021 Jan; 22(1):15. PubMed ID: 33389269
[TBL] [Abstract][Full Text] [Related]
9. Drug-printing by flexographic printing technology--a new manufacturing process for orodispersible films.
Janssen EM; Schliephacke R; Breitenbach A; Breitkreutz J
Int J Pharm; 2013 Jan; 441(1-2):818-25. PubMed ID: 23266759
[TBL] [Abstract][Full Text] [Related]
10. Prolonged release from orodispersible films by incorporation of diclofenac-loaded micropellets.
Speer I; Lenhart V; Preis M; Breitkreutz J
Int J Pharm; 2019 Jan; 554():149-160. PubMed ID: 30414477
[TBL] [Abstract][Full Text] [Related]
11. Development of orodispersible polymer films with focus on the solid state characterization of crystalline loperamide.
Woertz C; Kleinebudde P
Eur J Pharm Biopharm; 2015 Aug; 94():52-63. PubMed ID: 25976316
[TBL] [Abstract][Full Text] [Related]
12. Jet dispensing of multi-layered films for the co-delivery of three antihypertensive agents.
Scoutaris N; Malamatari M; Letellier A; Douroumis D
Drug Deliv Transl Res; 2018 Feb; 8(1):32-42. PubMed ID: 28967043
[TBL] [Abstract][Full Text] [Related]
13. Prolonged drug release properties for orodispersible films by combining hot-melt extrusion and solvent casting methods.
Speer I; Preis M; Breitkreutz J
Eur J Pharm Biopharm; 2018 Aug; 129():66-73. PubMed ID: 29792911
[TBL] [Abstract][Full Text] [Related]
14. SOFTs - Structured orodispersible film templates.
Steiner D; Finke JH; Kwade A
Eur J Pharm Biopharm; 2019 Apr; 137():209-217. PubMed ID: 30836181
[TBL] [Abstract][Full Text] [Related]
15. Model-based description of disintegration time and dissolution rate of nanoparticle-loaded orodispersible films.
Steiner D; Finke JH; Kwade A
Eur J Pharm Sci; 2019 Apr; 132():18-26. PubMed ID: 30794870
[TBL] [Abstract][Full Text] [Related]
16. Design of freeze-dried Soluplus/polyvinyl alcohol-based film for the oral delivery of an insoluble drug for the pediatric use.
Shamma R; Elkasabgy N
Drug Deliv; 2016; 23(2):489-99. PubMed ID: 24892631
[TBL] [Abstract][Full Text] [Related]
17. Comparative study on disintegration methods for oral film preparations.
Speer I; Steiner D; Thabet Y; Breitkreutz J; Kwade A
Eur J Pharm Biopharm; 2018 Nov; 132():50-61. PubMed ID: 30201569
[TBL] [Abstract][Full Text] [Related]
18. Preparation, characterization and in vitro evaluation of a polyvinyl alcohol/sodium alginate based orodispersible film containing sildenafil citrate.
Shi LL; Xu WJ; Cao QR; Yang M; Cui JH
Pharmazie; 2014 May; 69(5):327-34. PubMed ID: 24855822
[TBL] [Abstract][Full Text] [Related]
19. Key acceptability attributes of orodispersible films.
Scarpa M; Paudel A; Kloprogge F; Hsiao WK; Bresciani M; Gaisford S; Orlu M
Eur J Pharm Biopharm; 2018 Apr; 125():131-140. PubMed ID: 29355687
[TBL] [Abstract][Full Text] [Related]
20. Flexible and precise dosing of enalapril maleate for all paediatric age groups utilizing orodispersible minitablets.
Thabet Y; Walsh J; Breitkreutz J
Int J Pharm; 2018 Apr; 541(1-2):136-142. PubMed ID: 29474896
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
